Evidence map›Paper›PMID 24009242›Full record

ArticleBMJ (Clinical research ed.)2013

The effects of excluding treatments from network meta-analyses: survey.

Edward J Mills, Steve Kanters, Kristian Thorlund, Anna Chaimani, Areti-Angeliki Veroniki, John P A Ioannidis

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Outcomes of surgical techniques for parastomal hernia repair: a bayesian network meta-analysis.Hernia : the journal of hernias and abdominal wall surgery · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Network Meta-Analysis Techniques for Synthesizing Prevention Science Evidence.Prevention science : the official journal of the Society for Prevention Research · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edward J MillsFaculty of Health Sciences, University of Ottawa, Ottawa, Canada. edward.mills@uottawa.ca
Steve Kanters
Kristian Thorlund
Anna Chaimani
Areti-Angeliki Veroniki
John P A Ioannidis

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

objectiveTo examine whether the exclusion of individual treatment comparators, including placebo/no treatment, affects the results of network meta-analysis.

designSurvey of networks with individual trial data. DATA SOURCES: PubMed and communication with authors of network meta-analyses. STUDY SELECTION AND

methodsWe included networks that had five or more treatments, contained at least two closed loops, had at least twice as many studies as treatments, and had trial level data available. Investigators abstracted information about study design, participants, outcomes, network geometry, and the exclusion of eligible treatments.

resultsAmong 18 eligible networks involving 757 randomised controlled trials with 750 possible treatment comparisons, 11 had upfront decided not to consider all treatment comparators and only 10 included placebo/no treatment nodes. In 7/18 networks, there was at least one node whose removal caused a more than 1.10-fold average relative change in the estimated treatments effects, and switches in the top three treatments were observed in 9/18 networks. Removal of placebo/no treatment caused large relative changes of the treatment effects (average change 1.16-3.10-fold) for four of the 10 networks that had originally included placebo/no treatment nodes. Exclusion of current uncommonly used drugs resulted in substantial changes of the treatment effects (average 1.21-fold) in one of three networks on systemic treatments for advanced malignancies.

conclusionExcluding treatments in network meta-analyses sometimes can have important effects on their results and can diminish the usefulness of the research to clinicians if important comparisons are missing.

Indexed as

Clinical Trials as TopicMeta-Analysis as TopicPublication BiasHumans

Identifiers

PMID24009242
PMCPMC3763846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.